Physician profile

Bruce Johnson

Cookeville, TN

NPI 1982650289

$668.13

in general payments reported to CMS, 2019-2025

10 companies · none reported in 2025

Payments by year

General payments by program year, as reported to CMS.

What the payments were for

Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.

View as a table
Payment typeAmount (2023-2025)
Food and Beverage$178.08

Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.

Who reported paying

General payments only, as reported to CMS. Product names cover 2023-2025.

CompanyGeneral paymentsYearsTop products
Abiomed $254.84 2022-2023 Impella
Baxter Healthcare $148.48 2022-2023
Cardiovascular Systems INC. $98.78 2020
Stryker Corporation $75.80 2023 Na, Stryker Varispeed
Cordis US Corp. $20.41 2022
Insulet Corporation $19.82 2024 Omnipod
Chiesi USA, INC. $18.89 2020
Haemonetics Corporation $15.95 2021
Salix Pharmaceuticals, A Division of Bausch Health US, LLC $15.16 2020

1 company reported research payments only; those appear in the research section below.

Drugs and devices associated with these payments

CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.

If you want to bring it up

Most clinicians are glad to talk about this. A respectful way in:

These are normal questions. A good clinician will welcome them.

Share this page

Payment summary

Bruce Johnson

$668.13

in general payments reported 2019-2025

Years
2020-2024
Top company
Abiomed

https://glasscript.com/doctor/1295340/bruce-johnson

Source: CMS Open Payments, program years 2019-2025. Payments are legal and often routine.

Keep an eye on this page

Get an email when the next June refresh changes this page. No account needed.

Watch this doctor

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.